The Journal of Organic Chemistry
Page 14 of 17
1
2
3
4
5
6
7
8
9
N-(4,5-dimethyl-2-(pyridin-2-yl)acetamide (2j). The general procedure was followed using 2ꢀ
(3,4ꢀdimethylphenyl)pyridine (0.25 mmol, 46 mg), K2S2O8 (102 mg, 0.38 mmol), KOCN (40
mg, 0.50 mmol), Cu(OAc)2.H2O (100 mg, 0.50 mmol), PivOH (25 mg, 0.25 mmol), and toluene
(2 mL). Purification by column chromatography (silica gel, nꢀhexane/ EtOAc 1:1) gave the final
product 2j (41 mg, 68% yield) as a white solid; mp: 111 °C; 1HNMR (300 MHz, , CDCl3) δ
11.62 (s, 1H), 8.61 (d, J = 4.2 Hz, 1H), 8.13 (s, 1H), 7.87 (td, J = 7.8 Hz & J = 1.5Hz, 1H), 7.72
(d, J = 8.1Hz, 1H), 7.35 (s, 1H), 7.29 (t, J = 6.2Hz, 1H), 2.29 (s, 3H), 2.26 (s, 3H), 2.12 (s, 3H);
13CNMR (75 MHz, CDCl3) δ 168.7, 157.5, 146.3, 139.4, 138.7, 134.9, 132.4, 129.9, 124.1,
123.7, 123.4, 121.8, 24.9, 19.9, 19.3; IR(Film) 3236, 2923, 1678, 1585, 1521, 1448, 1396, 1290,
790, 590; HRMS (EI) m/z calculated for C15H16ON2 (M+): 240.1263. found: 240.1266.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
N-(4-chloro-2-(pyridin-2-yl)phenyl)acetamide(2k). The general procedure was followed using
2ꢀ(3ꢀchlorophenyl)pyridine (0.25 mmol, 47 mg), K2S2O8 (102 mg, 0.38 mmol), KOCN (40 mg,
0.50 mmol), Cu(OAc)2.H2O (100 mg, 0.50 mmol), PivOH (25 mg, 0.25 mmol), and toluene (2
mL). Purification by column chromatography (silica gel, nꢀhexane/ EtOAc 1:1) gave the final
product 2k (28 mg, 45% yield) as a white solid; mp:103 °C; 1HNMR (400 MHz, , CDCl3) 12.10
(s, 1H), 8.59 (d, J = 4.0 Hz, 1H), 8.49 (d, J = 8.0Hz, 1H), 7.77 (td, J = 4.0 Hz & J = 1.6Hz, 1H),
7.62 (d, J = 8.0Hz, 1H), 7.53 (d, J = 2.4 Hz, 1H), 7.25 (m, 2H), 2.12 (s, 3H); 13CNMR (100
MHz, CDCl3) δ 168.5, 156.8, 147.5, 137.9, 136.2, 129.9, 129.5, 128.3, 128.1, 123.0, 122.9,
121.7, 25.1; IR(Film) 3416, 2928, 1689, 1587, 1526, 1473, 1369, 1281, 784, 666; MS(EI) m/z
(relative intensity) 246 (M+ , 52), 231 (100), 203 (92), 168 (39), 140 (15), 79 (23). Anal. Calcd.
for C13H11ClN2O: C, 63.40; H, 4.51; N, 11.38; found: C, 63.35; H, 4.49; N, 11.36.
N-(4-(pyridin-2-yl)biphenyl-3-yl)acetamide (2l). The general procedure was followed using 2ꢀ
(biphenylꢀ4ꢀyl)pyridine (0.25 mmol, 58 mg), K2S2O8 (102 mg, 0.38 mmol), KOCN (40 mg, 0.50
mmol), Cu(OAc)2.H2O (100 mg, 0.50 mmol), PivOH (25 mg, 0.25 mmol), and toluene (2 mL).
Purification by column chromatography (silica gel, nꢀhexane/ EtOAc 1:1) gave the final product
1
2l (39 mg, 54% yield) as a brown oil; HNMR (400 MHz, , CDCl3) 12.30 (s, 1H), 8.90 (s, 1H),
8.69 (d, J = 4.8 Hz, 1H), 7.89 (td, J = 8.0 Hz & J = 1.6Hz, 1H), 7.82 (d, J = 8.0Hz, 1H), 7.74 (t,
J = 8.4 Hz, 2H), 7.47 (m, 3H), 7.39 (m, 2H), 7.32 (td, J = 5.2 Hz & J = 1.2 Hz, 1H), 2.25 (s,
3H); 13CNMR (100 MHz, CDCl3) δ 168.7, 158.1, 147.5, 142.7, 137.7, 129.1, 128.8, 128.7,
128.3, 127.7, 127.2, 127.1, 122.9, 121.9, 121.8, 120.4, 25.3; IR(Film) 3235, 3047, 1677, 1586,
1505, 1438, 1390, 1291, 764, 595; MS(EI) m/z (relative intensity) 288 (M+ , 41), 273 (100), 245
(71), 217 (23), 178 (39), 78 (18). Anal. Calcd. for C19H16N2O: C, 79.13; H, 5.60; N, 9.72; found:
C, 79.16; H, 5.59; N, 9.70
N-(2-(1H-pyrazol-1-yl)phenyl)acetamide (2m). The general procedure was followed using 1ꢀ
phenylꢀ1Hꢀpyrazole (0.25 mmol, 36 mg), K2S2O8 (102 mg, 0.38 mmol), KOCN (40 mg, 0.50
mmol), Cu(OAc)2.H2O (100 mg, 0.50 mmol), PivOH (25 mg, 0.25 mmol), and toluene (2 mL).
Purification by column chromatography (silica gel, nꢀhexane/ EtOAc 1:1) gave the final product
2m (16 mg, 31% yield) as a yellow oil; 1HNMR (500 MHz, , CDCl3) δ 10.23 (s, 1H), 8.44 (d, J
= 8.5 Hz, 1H), 7.79 (d, J = 2 Hz, 1H), 7.64 (d, J = 3 Hz, 1H), 7.34 (m, 2H), 7.13 (t, J = 7.8 Hz,
13
1H), 6.49 (t, J = 2.2 Hz, 1H), 2.12 (s, 3H); CNMR (125 MHz, CDCl3) δ 168.5, 141.4, 131.6,
130.2, 128.1, 127.1, 122.9, 122.4, 122.1, 107.2, 25.1; IR(Film) 3441, 2924, 2856, 1691, 1597,
ACS Paragon Plus Environment